Literature DB >> 7588309

LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.

C Leckie1, K E Chapman, C R Edwards, J R Seckl.   

Abstract

Mineralocorticoid receptors (MRs) are nonselective in vitro, binding corticosterone, cortisol, and aldosterone with similar affinity. In the distal nephron in vivo, MRs are selectively activated by aldosterone despite much higher glucocorticoid levels. This has been suggested to reflect the action of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD), which catalyzes rapid inactivation of corticosterone to 11-dehydrocorticosterone (cortisol to cortisone). However, cellular models of this effect have not been reported, and a recent study suggested that properties intrinsic to MR contribute to aldosterone selectivity. We have screened clonal mammalian cell lines for 11 beta-HSD activity. Pig kidney epithelial LLC-PK1 cells expressed by far the greatest 11 beta-HSD activity. In cell homogenates, this was NAD-dependent, with Km for corticosterone of 34.4 nM and cortisol of 89.7 nM. Intact LLC-PK1 cells showed similar apparent Km for corticosterone (13.9 nM) and cortisol (79.4 nM); only 11 beta-dehydrogenation was detected. These biochemical data indicate the expression of the type 2 isoform, 11 beta-HSD2. Using primers to conserved regions of 11 beta-HSD2, a reverse transcriptase-polymerase chain reaction product was obtained from LLC-PK1 cell RNA. Sequence analysis revealed close homology to previously cloned 11 beta-HSD2 cDNAs from several species. LLC-PK1 cell 11 beta-HSD activity was inhibited by carbenoxolone (IC50 approximately 10(-8) M) and high concentrations of estradiol or progesterone (10(-7) and 10(-6) M), but was induced at lower estradiol concentrations (10(-8) and 10(-9) M). To examine whether the 11 beta-HSD2 activity in LLC-PK1 cells regulates corticosterone access to MR, cells were transfected with the corticosteroid-inducible mouse mammary tumor virus long terminal repeat-luciferase reporter construct. Cell transfection by a lipofection method did not alter 11 beta-HSD activity in LLC-PK1 cells. LLC-PK1 cells expressed low levels of MR (13.9 fmol/mg protein, dissociation constant (Kd) 0.3 x 10(-9) M for aldosterone) and glucocorticoid receptors (GR; 18.5 fmol/mg protein, Kd 0.3 x 10(-9) M for dexamethasone). Transfection with mouse mammary tumor virus long terminal repeat-luciferase reporter construct alone suggested that the endogenous levels of MR and GR were insufficient to affect transcription. However, cotransfection of LLC-PK1 cells with pRShMR, an MR expression plasmid, allowed at least 50-fold induction of luciferase with 10(-8) M aldosterone; the ED50 0.3 x 10(-9) M closely reflects the in vitro affinity of MR for aldosterone. Corticosterone only weakly induced luciferase (maximum of 6-fold induction).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588309     DOI: 10.1210/endo.136.12.7588309

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions.

Authors:  R Diaz; R W Brown; J R Seckl
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

2.  Alternative splicing determines sensitivity of murine calcium-activated potassium channels to glucocorticoids.

Authors:  L Tian; M S Hammond; H Florance; F A Antoni; M J Shipston
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

3.  Effect of angiotensin II on rat renal cortical 11beta-hydroxysteroid dehydrogenase.

Authors:  M A Fischer; P M Schiffers; H A Struijker-Boudier
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

4.  Characterization of 11β-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK(1) : Evidence for a third isoform?

Authors:  E Möbus; J J Rob Hermans; E Maser
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

5.  Dex-ras1 and serum- and glucocorticoid-inducible protein kinase 1: regulation of expression by dexamethasone in HEK293 cells.

Authors:  Ghassem Attarzadeh-Yazdi; Michael J Shipston; Ferenc A Antoni
Journal:  Neurochem Res       Date:  2007-11-06       Impact factor: 3.996

6.  Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.

Authors:  Elise P Gomez-Sanchez; Damian G Romero; Angela F de Rodriguez; Mary P Warden; Zygmunt Krozowski; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

7.  Increased production of 11beta-hydroxysteroid dehydrogenase type 2 in the kidney microsomes of squirrel monkeys (Saimiri spp.).

Authors:  Patti W Sadosky; Jonathan G Scammell
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

8.  Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.

Authors:  Nina Queisser; Patricia I Oteiza; Samuel Link; Valentin Hey; Helga Stopper; Nicole Schupp
Journal:  Antioxid Redox Signal       Date:  2014-03-21       Impact factor: 8.401

Review 9.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.